Microbiome Signatures
Home » Knowledge Base » Apocynin Derived from Picrorhiza kurroa
Microbiome Signatures
Picrorhiza kurroa Kutki root and powder

Apocynin Derived from Picrorhiza kurroa

4 months ago9 min read Karen Pendergrass

Apocynin, a natural compound derived from Picrorhiza kurroa, has garnered significant attention due to its potential health benefits. This article aims to explore the impact of apocynin on human health, including its effects on the human microbiome and its role in various diseases. The human microbiome, comprising trillions of microorganisms residing in and on our bodies, plays a crucial role in various physiological processes and disease development. Emerging evidence suggests that apocynin may modulate the composition and function of the human microbiome, thereby influencing disease outcomes. This review discusses the potential mechanisms through which apocynin derived from Picrorhiza kurroa affects human health and disease.

Keywords: Apocynin, Picrorhiza kurroa, human microbiome, health, disease, gut microbiota, microbial diversity.

1. Introduction

The human microbiome, consisting of bacteria, archaea, fungi, and viruses, has emerged as a key determinant of human health and disease. Recent research has highlighted the potential of apocynin, a natural compound derived from Picrorhiza kurroa, in modulating the human microbiome and influencing disease outcomes. This article aims to provide an overview of the impact of apocynin on the human microbiome and its implications for human health and disease.

2. Apocynin and Its Sources


Apocynin is primarily obtained from the roots of Picrorhiza kurroa, an herbaceous plant indigenous to the Himalayan region. It belongs to the class of compounds known as acetophenones and has gained attention for its anti-inflammatory, antioxidant, and immunomodulatory properties. While traditionally used in Ayurvedic medicine, recent studies have focused on its potential effects on the human microbiome and its role in various diseases.

3. Apocynin and the Human Microbiome

Apocynin has been shown to influence the composition and diversity of the human microbiome. Studies have demonstrated its ability to modulate the gut microbiota, which is particularly relevant due to its impact on systemic health. Apocynin’s interaction with the human microbiome is thought to occur through various mechanisms, including direct antimicrobial effects and modulation of microbial metabolism.

4. Apocynin in Disease Research

4.1 Inflammatory Bowel Disease (IBD): Apocynin has been investigated for its potential therapeutic effects in IBD, including ulcerative colitis and Crohn’s disease. Studies have suggested that apocynin may attenuate inflammation and oxidative stress in the gut, providing potential benefits in IBD management[x][x].

4.2 Cardiovascular Diseases: Apocynin has shown promise in cardiovascular disease research. It has been studied for its potential to reduce oxidative stress and inflammation, improving cardiac function in conditions such as hypertension, atherosclerosis, and heart failure [x][x][x].

4.3 Neurodegenerative Diseases: Preclinical studies have explored the effects of apocynin in neurodegenerative disorders, including Alzheimer’s disease, Parkinson’s disease, and Multiple Sclerosis. Apocynin’s antioxidant and anti-inflammatory properties have shown potential in reducing neuroinflammation and protecting neuronal cells [x][x][x][x].

5. Mechanisms of Action

5.1 General: The leaves and rhizome of picrorhiza contain relevant components with potential benefits.Among these constituents, picroside emerges as a prominent active compound [x]. Picroliv, a mixture of iridoid glycosides including picroside, kutkoside, cucurbitacin glycosides, and other yet unidentified elements, is derived from picrorhiza. [x] [x] [x] [x]

5.2 Anti-asthmatic effects: Picrorhiza, renowned for its historical usage in the treatment of asthma, holds potential as an agent with immunostimulant and antiallergic properties. It is believed that the plant exerts these effects by potentially stabilizing mast cells, contributing to its therapeutic value. [x] The presence of androsin, a constituent found in picrorhiza, is believed to play a contributory role in its antiallergic effect. Specifically, androsin is thought to exert its influence by inhibiting platelet-activating factor, further enhancing the plant’s therapeutic potential. [x]

5.3 Anticancer properties: Evidence suggests that picroliv, a constituent found in picrorhiza, demonstrates notable anticarcinogenic properties when administered orally or topically in experimental models of liver and skin cancer. Notably, picroliv exhibits potential in inhibiting topoisomerase I and II, mechanisms that can effectively impede cancer cell proliferation, further augmenting its anticancer effects. [x] [x]

5.4 Anti-inflammatory effects: Emerging research indicates that apocynin, a constituent found in picrorhiza, possesses noteworthy anti-inflammatory properties. Preclinical studies conducted in animals suggest that apocynin holds promise as a potential therapeutic agent for combating arthritis due to its potential anti-arthritic activity. [x] [x] [x]

5.5 Antimicrobial effects: The picrorhiza extract known as picroliv exhibits remarkable activity against parasitic organisms, including Leishmania donovani, the causative agent of leishmaniasis, and Plasmodium berghei, the pathogen responsible for malaria. These findings underscore the potential of picroliv as a valuable tool in combating these parasitic infections. [x] [x]

5.6 Cardioprotective effects: A compelling animal study demonstrated that pre-administration of the ethanol extract derived from picrorhiza rhizomes and roots effectively mitigated experimentally induced myocardial infarction. Notably, this treatment exhibited the ability to preserve optimal lipid metabolism, highlighting its potential as a preventive measure in maintaining cardiovascular health. [x]

5.7 Hepatoprotective effects: Picroliv, an extract derived from picrorhiza, demonstrates notable hepatoprotective properties, as supported by scientific evidence[x]. It exhibits a remarkable ability to shield the liver against hepatotoxic agents, including ethanol and the Amanita mushroom, known for their detrimental effects on liver health. This underscores the potential of picroliv as a valuable therapeutic agent for liver protection.[x][x][x][x]

The observed hepatoprotective effect, attributed to picroliv, can be attributed to its potential in inhibiting lipid peroxidation and mitigating the generation of free radicals. By reducing the formation of reactive metabolites, picroliv demonstrates a significant capacity to safeguard the liver against damage, providing a plausible mechanistic explanation for its hepatoprotective properties. [x] [x]

5.8 Immunological effects: Compelling data derived from animal studies strongly indicate that both the leaves and rhizomes of picrorhiza possess remarkable immunostimulatory properties [x]. These immunostimulatory actions of picrorhiza are thought to play a pivotal role in ameliorating vitiligo, suggesting its potential as a therapeutic intervention for this condition [x].

5.9 Wound healing properties: Compelling in vivo and ex vivo investigations have elucidated that picroliv, an extract derived from picrorhiza, exhibits the capacity to up-regulate the expression of key factors such as vascular endothelial growth factor and insulin-like growth factor. This modulation consequently contributes to enhanced wound re-epithelialization, neovascularization, and the facilitation of cellular migration among critical cell types such as endothelial cells, dermal myofibroblasts, and fibroblasts. These findings underscore the potential of picroliv as a promising therapeutic intervention for promoting wound healing and tissue regeneration.[x]

5. Conclusion

Apocynin derived from Picrorhiza kurroa shows promising potential in modulating the human microbiome and influencing disease outcomes. Apocynin may impact various physiological processes and contribute to disease prevention or management through its interactions with the microbiome. Investigations into its effects on inflammatory bowel disease, cardiovascular diseases, and neurodegenerative disorders have yielded encouraging results. However, further research is needed to understand the underlying mechanisms fully and to explore the clinical applications of apocynin in relation to the human microbiome and disease treatment.

References:

  1. Hwang YJ, Nam SJ, Chun W, Kim SI, Park SC, Kang CD, Lee SJ. Anti-inflammatory effects of apocynin on dextran sulfate sodium-induced mouse colitis model. PLoS One. 2019 May 29;14(5):e0217642. doi: 10.1371/journal.pone.0217642. PMID: 31141554; PMCID: PMC6541291.
  2. S C Park and others, P025 Protective effect and action mechanism of apocynin in IBD mouse model, Journal of Crohn’s and Colitis, Volume 12, Issue supplement_1, February 2018, Page S106, https://doi.org/10.1093/ecco-jcc/jjx180.152
  3. Virdis, A., Gesi, M., & Taddei, S. (2016). Impact of apocynin on vascular disease in hypertension. Vascular Pharmacology, 87, 1–5. doi:10.1016/j.vph.2016.08.006 
  4. Touyz, R. M. (2007). Apocynin, NADPH Oxidase, and Vascular Cells: A Complex Matter. Hypertension, 51(2), 172–174. doi:10.1161/hypertensionaha.107.103200 
  5. Liu, Y., Liu, Y., Liu, X., Chen, J., Zhang, K., Huang, F., … Huang, H. (2015). Apocynin Attenuates Cardiac Injury in Type 4 Cardiorenal Syndrome via Suppressing Cardiac Fibroblast Growth Factor‐2 With Oxidative Stress Inhibition. Journal of the American Heart Association, 4(7). doi:10.1161/jaha.114.001598 
  6. Joseph, E., Villalobos-Acosta, D. M. Á., Torres-Ramos, M. A., Farfán-García, E. D., Gómez-López, M., Miliar-García, Á., … Rosales-Hernández, M. C. (2019). Neuroprotective Effects of Apocynin and Galantamine During the Chronic Administration of Scopolamine in an Alzheimer’s Disease Model. Journal of Molecular Neuroscience. doi:10.1007/s12031-019-01426-5 
  7. Ghosh, A., Kanthasamy, A., Joseph, J., Anantharam, V., Srivastava, P., Dranka, B. P., … Kanthasamy, A. G. (2012). Anti-inflammatory and neuroprotective effects of an orally active apocynin derivative in pre-clinical models of Parkinson’s disease. Journal of Neuroinflammation, 9(1). doi:10.1186/1742-2094-9-241 
  8. Nascimento, A., Medeiros, P. Pedrão, L… (2022). Oxidative Stress Inhibition Via Apocynin Prevents Medullary Respiratory Neurodegeneration and Respiratory Pattern Dysfunction in a 6-Hydroxydopamine Animal Model of Parkinson’s Disease. Journal of Neuroscience.  doi:10.1016/j.neuroscience.2022.07.034
  9. Choi, B. Y., Kim, J. H., Kho, A. R., Kim, I. Y., Lee, S. H., Lee, B. E., … Suh, S. W. (2015). Inhibition of NADPH oxidase activation reduces EAE-induced white matter damage in mice. Journal of Neuroinflammation, 12(1). doi:10.1186/s12974-015-0325-5 
  10. Vaidya AB, Antarkar DS, Doshi JC, Bhatt AD, Ramesh V, Vora PV, Perissond D, Baxi AJ, Kale PM. Picrorhiza kurroa (Kutaki) Royle ex Benth as a hepatoprotective agent–experimental & clinical studies. J Postgrad Med. 1996 Oct-Dec;42(4):105-8. PMID: 9715310.
  11. Rastogi, R., Srivastava, A. K., & Rastogi, A. K. (2001). Long term effect of aflatoxin B1 on lipid peroxidation in rat liver and kidney: effect of picroliv and silymarin. Phytotherapy Research, 15(4), 307–310. doi:10.1002/ptr.722 
  12. Saraswat, B., Visen, P. K. ., Patnaik, G. ., & Dhawan, B. . (1999). Ex vivo and in vivo investigations of picroliv from Picrorhiza kurroa in an alcohol intoxication model in rats. Journal of Ethnopharmacology, 66(3), 263–269. doi:10.1016/s0378-8741(99)00007-0 
  13. Dwivedi Y, Rastogi R, Garg NK, Dhawan BN. Effects of picroliv, the active principle of Picrorhiza kurroa, on biochemical changes in rat liver poisoned by Amanita phalloides. Zhongguo Yao Li Xue Bao. 1992 May;13(3):197-200. PMID: 1359730.
  14. Mehrotra R, Rawat S, Kulshreshtha DK, Patnaik GK, Dhawan BN. In vitro studies on the effect of certain natural products against hepatitis B virus. Indian J Med Res. 1990 Apr;92:133-8. PMID: 2370093.
  15. BARUAH, C. C., GUPTA, P. P., NATH, A., PATNAIK, L. G. K., & DHAWAN, B. N. (1998). ANTI-ALLERGIC AND ANTI-ANAPHYLACTIC ACTIVITY OF PICROLIV—A STANDARDISED IRIDOID GLYCOSIDE FRACTION OFPICRORHIZA KURROA. Pharmacological Research, 38(6), 487–492. doi:10.1006/phrs.1998.0397
  16. Dorsch W, Stuppner H, Wagner H, Gropp M, Demoulin S, Ring J. Antiasthmatic effects of Picrorhiza kurroa: androsin prevents allergen- and PAF-induced bronchial obstruction in guinea pigs. Int Arch Allergy Appl Immunol. 1991;95(2-3):128-33. doi: 10.1159/000235416.
  17. Rajeshkumar, N. V., & Kuttan, R. (2001). Protective effect of Picroliv, the active constituent ofPicrorhiza kurroa, against chemical carcinogenesis in mice. Teratogenesis, Carcinogenesis, and Mutagenesis, 21(4), 303–313. doi:10.1002/tcm.1018 
  18. Rajeshkumar NV, Kuttan R. Inhibition of N-nitrosodiethylamine-induced hepatocarcinogenesis by Picroliv. J Exp Clin Cancer Res. 2000 Dec;19(4):459-65. PMID: 11277323.
  19. Jia Q, Hong MF, Minter D. Pikuroside: a novel iridoid from Picrorhiza kurroa. J Nat Prod. 1999 Jun;62(6):901-3. doi: 10.1021/np980493+. PMID: 10395515.
  20. Van den Worm, E., Beukelman, C. J., Van den Berg, A. J. ., Kroes, B. H., Labadie, R. P., & Van Dijk, H. (2001). Effects of methoxylation of apocynin and analogs on the inhibition of reactive oxygen species production by stimulated human neutrophils. European Journal of Pharmacology, 433(2-3), 225–230. doi:10.1016/s0014-2999(01)01516-3 
  21. ’T Hart, B. A., Simons, J. M., Shoshan, K.-S., Bakker, N. P. M., & Labadie, R. P. (1990). Antiarthritic activity of the newly developed neutrophil oxidative burst antagonist apocynin. Free Radical Biology and Medicine, 9(2), 127–131. doi:10.1016/0891-5849(90)90115-y 
  22. Chander R, Singh K, Visen PK, Kapoor NK, Dhawan BN. Picroliv prevents oxidation in serum lipoprotein lipids of Mastomys coucha infected with Plasmodium berghei. Indian J Exp Biol. 1998 Apr;36(4):371-4. PMID: 9717447.
  23. Mittal N, Gupta N, Saksena S, Goyal N, Roy U, Rastogi AK. Protective effect of Picroliv from Picrorhiza kurroa against Leishmania donovani infections in Mesocricetus auratus. Life Sci. 1998;63(20):1823-34. doi: 10.1016/s0024-3205(98)00456-1.
  24. Hari Senthil Kumar, S., Anandan, R., Devaki, T., & Santhosh Kumar, M. (2001). Cardioprotective effects of Picrorrhiza kurroa against isoproterenol-induced myocardial stress in rats. Fitoterapia, 72(4), 402–405. doi:10.1016/s0367-326x(01)00264-7 
  25. Vaidya AB, Antarkar DS, Doshi JC, Bhatt AD, Ramesh V, Vora PV, Perissond D, Baxi AJ, Kale PM. Picrorhiza kurroa (Kutaki) Royle ex Benth as a hepatoprotective agent–experimental & clinical studies. J Postgrad Med. 1996 Oct-Dec;42(4):105-8. PMID: 9715310.
  26. Rastogi, R., Srivastava, A. K., & Rastogi, A. K. (2001). Long term effect of aflatoxin B1 on lipid peroxidation in rat liver and kidney: effect of picroliv and silymarin. Phytotherapy Research, 15(4), 307–310. doi:10.1002/ptr.722 
  27. Saraswat, B., Visen, P. K. ., Patnaik, G. ., & Dhawan, B. . (1999). Ex vivo and in vivo investigations of picroliv from Picrorhiza kurroa in an alcohol intoxication model in rats. Journal of Ethnopharmacology, 66(3), 263–269. doi:10.1016/s0378-8741(99)00007-0 
  28. Dwivedi Y, Rastogi R, Garg NK, Dhawan BN. Effects of picroliv, the active principle of Picrorhiza kurroa, on biochemical changes in rat liver poisoned by Amanita phalloides. Zhongguo Yao Li Xue Bao 1992;13:197-200. 
  29. Mehrotra R, Rawat S, Kulshreshtha DK, Patnaik GK, Dhawan BN. In vitro studies on the effect of certain natural products against hepatitis B virus. Indian J Med Res. 1990 Apr;92:133-8. PMID: 2370093.
  30. Ansari, R. A., Tripathi, S. C., Patnaik, G. K., & Dhawan, B. N. (1991). Antihepatotoxic properties of picroliv: an active fraction from rhizomes of Picrorhiza kurrooa. Journal of Ethnopharmacology, 34(1), 61–68. doi:10.1016/0378-8741(91)90189-k 
  31. Chander, R., Kapoor, N. K., & Dhawan, B. N. (1992). Picroliv, picroside-I and kutkoside from Picrorhiza kurrooa are scavengers of superoxide anions. Biochemical Pharmacology, 44(1), 180–183. doi:10.1016/0006-2952(92)90054-m 
  32. Bedi, K. L., Zutshi, U., Chopra, C. L., & Amla, V. (1989). Picrorhiza kurroa, an ayurvedic herb, may potentiate photochemotherapy in vitiligo. Journal of Ethnopharmacology, 27(3), 347–352. doi:10.1016/0378-8741(89)90009-3
  33. Singh, A., Sharma, A., Warren, J., Madhavan, S., Steele, K., RajeshKumar, N., … Maheshwari, R. (2007). Picroliv Accelerates Epithelialization and Angiogenesis in Rat Wounds. Planta Medica, 73(3), 251–256. doi:10.1055/s-2007-967119 

Was this article helpful?
About the author
Karen Pendergrass

Related articles